Clinical Trials Browser

Phase 1 × Leukemia, Myeloid, Acute × Hydroxyurea × Clear all

NCT06871410 2026-03-24

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute